CSIMarket
 


Grifols Sa  (GRFS)
Other Ticker:  
 
 

GRFS's Net Income Growth by Quarter and Year

Grifols Sa's Net Income results by quarter and year




GRFS Net Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December 794.07 726.48 665.73 661.31
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   794.07 726.48 665.73 661.31



GRFS Net Income forth quarter 2020 Y/Y Growth Comment
Grifols Sa showed record Net Income improvement in the forth quarter with 9.3% from the forth quarter 2019, to $ 794.07 millions.

Looking into forth quarter results within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Net Income growth. While Grifols Sa' s Net Income increase of 9.3% ranks overall at the positon no. 809 in the forth quarter.




GRFS Net Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December 9.3 % 9.13 % 0.67 % -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   9.3 % 9.13 % 0.67 % -

Financial Statements
Grifols Sa's forth quarter 2020 Net Income $ 794.07 millions GRFS's Income Statement
Grifols Sa's forth quarter 2019 Net Income $ 726.48 millions Quarterly GRFS's Income Statement
New: More GRFS's historic Net Income Growth >>


GRFS Net Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   9.3 % 9.13 % 0.67 % -




Net Income forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #22
Healthcare Sector #78
Overall #809

Net Income Y/Y Growth Statistics
High Average Low
9.3 % 9.21 % 9.12 %
(Dec 31 2020)   (Dec 31 2019)
Net Income forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #22
Healthcare Sector #78
Overall #809
Net Income Y/Y Growth Statistics
High Average Low
9.3 % 9.21 % 9.12 %
(Dec 31 2020)   (Dec 31 2019)

Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Grifols Sa's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
-100 % -100 % -100 %
0  


GRFS's IV. Quarter Q/Q Net Income Comment


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Statistics
High Average Low
-100 % -100 % -100 %
0  


GRFS's IV. Quarter Q/Q Net Income Comment


Grifols Sa's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Net Income 12 Months Ending $ 794.07 $ 726.48 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) 9.3 % 9.12 % - - -
Year on Year Net Income Growth Overall Ranking # 759 # 0 # 0 # 0 # 0
Seqeuential Net Income Change (TTM) 9.3 % 9.12 % - - -
Seq. Net Income Growth (TTM) Overall Ranking # 809 # 0 # 0 # 0 # 0




Cumulative Net Income growth Comment
With 9.3% annual Net Income growth, Grifols Sa would report a record annual Net Income improvement if the fiscal year would end on Dec 31 2020.

In the Healthcare sector 72 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 759.

Net Income TTM Q/Q Growth Statistics
High Average Low
9.3 %
9.21 %
9.12 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 73
Overall # 759

Net Income TTM Y/Y Growth Statistics
High Average Low
9.3 %
9.21 %
9.12 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 78
S&P 500 # 809
Cumulative Net Income growth Comment
With 9.3% annual Net Income growth, Grifols Sa would report a record annual Net Income improvement if the fiscal year would end on Dec 31 2020.

In the Healthcare sector 72 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 759.

Net Income TTM Q/Q Growth Statistics
High Average Low
9.3 %
9.21 %
9.12 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 73
Overall # 759

Net Income TTM Y/Y Growth Statistics
High Average Low
9.3 %
9.21 %
9.12 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 78
S&P 500 # 809




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
GRFS's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for GRFS's Competitors
Net Income Growth for Grifols Sa's Suppliers
Net Income Growth for GRFS's Customers

You may also want to know
GRFS's Annual Growth Rates GRFS's Profitability Ratios GRFS's Asset Turnover Ratio GRFS's Dividend Growth
GRFS's Roe GRFS's Valuation Ratios GRFS's Financial Strength Ratios GRFS's Dividend Payout Ratio
GRFS's Roa GRFS's Inventory Turnover Ratio GRFS's Growth Rates GRFS's Dividend Comparisons



Companies with similar Net Income improvement for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2020
Cellect Biotechnology Ltd 15.63%$ 15.628 millions
Novocure Limited15.42%$ 15.423 millions
Mettler Toledo International Inc12.22%$ 12.216 millions
Resmed Inc 11.81%$ 11.809 millions
Petmed Express Inc11.27%$ 11.272 millions
Edwards Lifesciences Corporation10.46%$ 10.457 millions
Steris Plc9.48%$ 9.479 millions
Grifols Sa9.30%$ 9.303 millions
Phibro Animal Health Corp7.63%$ 7.626 millions
Prestige Consumer Healthcare Inc 6.70%$ 6.700 millions
Haemonetics Corporation6.65%$ 6.647 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NXU's Profile

Stock Price

NXU's Financials

Business Description

Fundamentals

Charts & Quotes

NXU's News

Suppliers

NXU's Competitors

Customers & Markets

Economic Indicators

NXU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071